Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice

International Immunology

Volumn 21, Issue 8, 2009, Pages 905-912

  Murakami, Taisuke ^a   Obata, Toru ^b   Kuwahara Arai, Kyoko ^a   Tamura, Hiroshi ^c   Hiramatsu, Keiichi ^a   Nagaoka, Isao ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Seikagaku Biobusiness Corporation   (Japan)

Author keywords

Anandamide; HMGB1; Host defense peptide; Innate immunity

Indexed keywords

ANANDAMIDE; CATHELICIDIN ANTIMICROBIAL PEPTIDE 11; GALACTOSAMINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL RATE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ARACHIDONIC ACIDS; CELL LINE; CYTOKINES; DOWN-REGULATION; GALACTOSAMINE; HMGB1 PROTEIN; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; POLYUNSATURATED ALKAMIDES; SHOCK, SEPTIC;

EID: 70349487951     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp057     Document Type: Article

References (34)

1. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885.
2. Van Amersfoort, E. S., Van Berkel, T. J. and Kuiper, J. 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev. 16:379.
3. O'Brien, J. M., Jr, Ali, N. A., Aberegg, S. K. and Abraham, E. 2007. Sepsis. Am. J. Med. 120:1012.
4. Wang, H., Yang, H., Czura, C. J., Sama, A. E. and Tracey, K. J. 2001. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164:1768.
5. Wang, H., Yang, H. and Tracey, K. J. 2004. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255:320.
6. Dumitriu, I. E., Baruah, P., Manfredi, A. A., Bianchi, M. E. and Rovere-Querini, P. 2005. HMGB1: Guiding immunity from within. Trends Immunol. 26:381.
7. Varga, K., Wagner, J. A., Bridgen, D. T. and Kunos, G. 1998. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 12:1035.
8. Wang, Y., Liu, Y., Ito, Y. et al. 2001. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal. Biochem. 294:73.
9. Wang, H., Bloom, O., Zhang, M. et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248.
10. Park, J. S., Arcaroli, J., Yum, H. K. et al. 2003. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284:C870.
11. Andersson, U., Wang, H., Palmblad, K. et al. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565.
12. Fiuza, C., Bustin, M., Talwar, S. et al. 2003. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101:2652.
13. Yang, H., Wang, H., Czura, C. J. and Tracey, K. J. 2002. HMGB1 as a cytokine and therapeutic target. J. Endotoxin Res. 8:469.
14. Pacher, P., Batkai, S. and Kunos, G. 2004. Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. J. Physiol. 558:647.
15. Sakamoto, Y., Mashiko, K., Obata, T. et al. 2008. Effectiveness of continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter after polymyxin B-immobilized fiber column therapy of septic shock. ASAIO J. 54:129.
16. Roche, M., Kelly, J. P., O'Driscoll, M. and Finn, D. P. 2008. Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats. Immunology 125:263.
17. Riedemann, N. C., Guo, R. F. and Ward, P. A. 2003. Novel strategies for the treatment of sepsis. Nat. Med. 9:517.
18. Riedemann, N. C., Guo, R. F. and Ward, P. A. 2003. The enigma of sepsis. J. Clin. Invest. 112:460.
19. Selsted, M. E. and Ouellette, A. J. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551.
20. Niyonsaba, F., Nagaoka, I. and Ogawa, H. 2006. Human defensins and cathelicidins in the skin: Beyond direct antimicrobial properties. Crit. Rev. Immunol. 26:545.
21. Gennaro, R. and Zanetti, M. 2000. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55:31.
22. Yomogida, S., Nagaoka, I. and Yamashita, T. 1996. Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch. Biochem. Biophys. 328:219.
23. Nagaoka, I., Hirota, S., Niyonsaba, F. et al. 2001. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J. Immunol. 167:3329.
24. Murakami, T., Yomogida, S., Someya, A., Kuwahara-Arai, K., Tamura, H. and Nagaoka, I. 2007. Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from lipopolysaccharide-stimulated mononuclear phagocytes. FEBS Lett. 581:140.
25. Sakamoto, Y., Mashiko, K., Obata, T. et al. 2007. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock. ASAIO J. 53:646.
26. Galanos, C., Freudenberg, M. A. and Reutter, W. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl Acad. Sci. USA 76:5939.
27. Yang, H., Wang, H., Czura, C. J. and Tracey, K. J. 2005. The cytokine activity of HMGB1. J. Leukoc. Biol. 78:1.
28. Kohro, S., Imaizumi, H., Yamakage, M. et al. 2006. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J. Anesth. 20:11.
29. Obata, T., Sakurai, Y., Kase, Y., Tanifuji, Y. and Horiguchi, T. 2003. Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2alpha) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 792:131.
30. Matsuda, K., Mikami, Y., Takeda, K. et al. 2005. The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. Tohoku J. Exp. Med. 207:99.
31. Willoughby, K. A., Moore, S. F., Martin, B. R. and Ellis, E. F. 1997. The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282:243.
32. Sun, Y. X., Tsuboi, K., Zhao, L. Y., Okamoto, Y., Lambert, D. M. and Ueda, N. 2005. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N acylethanolamines in macrophages. Biochim. Biophys. Acta 1736:211.
33. Cohen, J. 2000. The detection and interpretation of endotoxaemia. Intensive Care Med. 26 (Suppl. 1):S51.
34. Annane, D., Bellissant, E. and Cavaillon, J. M. 2005. Septic shock. Lancet 365:63.